Literature DB >> 2427824

Interactions of thromboxane A2 analogs and prostaglandins in isolated dog arteries.

N Toda, M Nakajima, T Okamura, M Miyazaki.   

Abstract

Interactions of ONO3708, a thromboxane (TX) A2 analog, and epithio-methano-TXA2 (sTXA2) or prostaglandins (PGs) were investigated in helical strips of dog cerebral, coronary, renal, and mesenteric arteries. In these arterial strips sTXA2 (10(-10) to 10(-7) M) produced a dose-dependent contraction, whereas ONO3708 up to 10(-6) M failed to contract the arteries but antagonized the contractile response to sTXA2. The inhibition tended to be greater in renal arteries than in the other arteries. Contractions induced by PGF2 alpha, PGE2, and PGD2 were also suppressed by treatment with low concentrations (3 X 10(-9) and 10(-8) M) of ONO3708. The attenuations of the response to sTXA2, PGF2 alpha, PGE2, and PGD2 did not appreciably differ. Norepinephrine-induced contractions were not influenced by ONO3708 up to 2 X 10(-7) M. On the other hand, relaxant responses to PGI2 of cerebral and renal arteries were not reduced by ONO3708. Prostaglandin H2 produced a transient contraction followed by a relaxation in cerebral and renal arteries. The contractile response was abolished by 10(-7) M ONO3708, and the relaxation was potentiated. It may be concluded that ONO3708 selectively antagonizes the vasoconstrictor action of TXA2, its analogs, and PGs but does not alter the action of vasodilator PGs. At least in part, sTXA2, PGF2 alpha, PGE2, and PGD2 appear to share the same receptive site responsible for vascular contraction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427824     DOI: 10.1097/00005344-198709010-00025

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.

Authors:  A H Krauss; D F Woodward; L L Gibson; C E Protzman; L S Williams; R M Burk; T S Gac; M B Roof; F Abbas; K Marshall; J Senior
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries.

Authors:  T Okamura; M Nakajima; N Toda
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

3.  Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.

Authors:  H Sakai; T Sato; N Hamada; M Yasue; A Ikari; B Kakinoki; N Takeguchi
Journal:  J Physiol       Date:  1997-11-15       Impact factor: 5.182

4.  The effects of a thromboxane A2 receptor antagonist on neurologic recovery after 15 min complete global brain ischemia in dogs.

Authors:  M Takahashi; N Iwatsuki; K Ono; T Tazima; Y Koga; Y Hashimoto
Journal:  J Anesth       Date:  1991-01       Impact factor: 2.078

5.  Vasoactivity of prostanoids in the trout (Oncorhynchus mykiss) coronary system: modification by noradrenaline.

Authors:  T Mustafa; C Agnisola
Journal:  Fish Physiol Biochem       Date:  1994-07       Impact factor: 2.794

6.  Ipratropium bromide protects against bronchoconstriction during bronchoscopy.

Authors:  H Inoue; H Aizawa; S Takata; H Koto; K Matsumoto; M Shigyo; N Hara
Journal:  Lung       Date:  1994       Impact factor: 2.584

7.  The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.

Authors:  H Giles; P Leff; M L Bolofo; M G Kelly; A D Robertson
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

8.  Prostaglandins involved in contractions by angiotensin II and bradykinin of isolated dog sphincter pupillae.

Authors:  W Lu; T Okamura; K Bian; A Inatomi; N Toda
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

9.  Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism.

Authors:  Y Fujii; J Sakurai
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

10.  Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.

Authors:  P M Tymkewycz; R L Jones; N H Wilson; C G Marr
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.